[Multiple myeloma transforming into acute leukaemia (author's transl)]. 1977

J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
January 1976, Deutsche medizinische Wochenschrift (1946),
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
January 1979, Nouvelle revue francaise d'hematologie,
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
March 1980, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
December 1977, Aichi Gakuin Daigaku Shigakkai shi,
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
January 1981, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
September 1980, La Nouvelle presse medicale,
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
November 1977, Journal of the Indian Medical Association,
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
January 1980, Sangre,
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
September 1980, Klinische Wochenschrift,
J Mayans, and J Redon, and L Badia, and C Herranz, and J R Calabuig, and M A Sanz, and A Soler, and M Caballero, and M L Marty
January 1981, Nouvelle revue francaise d'hematologie,
Copied contents to your clipboard!